Fortrea Holdings Inc (FTRE) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Fortrea Holdings Inc   (NASDAQ: FTRE)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Fortrea Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



FTRE Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -4.52 %
Seq. Revenue Change 6.55 %
Revenue In Millions $678.20
Gross Profit Margin 20.52 %
Gross Profit Margin Total Ranking # 2921
Gross Profit In Millions $139.20
Y / Y Gross Profit Change -
Seq. Gross Profit Change 12.62 %


Commenting Second Quarter 2026 Gross Profit Margin
Fortrea Holdings Inc Gross Profit grew by 12.62 % in Q2 sequentially to 139 millions, while Revenue increased by 6.55 %, this led to improvement in the company's Gross Profit Margin to 20.52 %, above the Fortrea Holdings Inc average Gross Profit Margin.


Observing second quarter 2026 results within Medical Laboratories industry 25 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2921, from total ranking in the previous quarter at 3274.
Learn about Gross Margin
FTRE's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 26
Healthcare Sector # 415
Overall # 2899

Gross Profit Margin Statistics
High Average Low
31.94 % 19.9 % 16.3 %
(Dec 31 2023)   (Mar 31 2024)




Other Gross Profit Margin Profitability Ratios
FTRE's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
FTRE's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for FTRE's Competitors
Gross Profit Margin Profit Margin for Fortrea Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for FTRE's Customers

You may also want to know
FTRE's Annual Growth Rates FTRE's Profitability Ratios FTRE's Asset Turnover Ratio FTRE's Dividend Growth
FTRE's Roe FTRE's Valuation Ratios FTRE's Financial Strength Ratios FTRE's Gross Profit Growth
FTRE's Roa FTRE's Inventory Turnover Ratio FTRE's Growth Rates FTRE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Laboratories Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Ispecimen inc   45.18 %$ 0.069  Millions$ 0.152  Millions
Quest Diagnostics Inc  33.75 %$ 1,027.000  Millions$ 3,043.000  Millions
Aclarion Inc   32.93 %$ 0.008  Millions$ 0.025  Millions
Fulgent Genetics Inc   30.07 %$ 25.679  Millions$ 85.389  Millions
Labcorp Holdings Inc   29.80 %$ 1,112.000  Millions$ 3,731.100  Millions
Medpace Holdings Inc   28.51 %$ 201.637  Millions$ 707.331  Millions
Personalis Inc   21.21 %$ 4.743  Millions$ 22.357  Millions
Fortrea Holdings Inc   20.52 %$ 139.200  Millions$ 678.200  Millions
Bionexus Gene Lab Corp   17.05 %$ 0.013  Millions$ 0.076  Millions
American Shared Hospital Services  17.00 %$ 1.433  Millions$ 8.430  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.